Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Systemic Psoriasis Treatments Less Often Prescribed in Elderly With Psoriasis

Key clinical point: Biologics are underprescribed in the elderly, despite evidence that the efficacy of biologics is comparable between older and younger patients over time.

Major finding: Biologics were used more frequently in younger patients, but response rates to systemic therapies, including nonbiologics, were generally comparable between the elderly and controls.

Study details: An analysis of patient data in German and Swiss psoriasis registries, including approximately 765 individuals aged 65 years or older and 4,600 younger patients.

Disclosures: The PsoBest registry is sponsored by CVderm, DDG, and BVDD. The Swiss registry is supported by Janssen, AbbVie, Pfizer, Celgene, Lilly, and Novartis. Dr. Augustin did not provide disclosure information.